Illinois-based pharmaceutical company.
Found 4 search result(s) for Abbott.
Kempf, Dale J.
(HIV/AIDS Research: Its History & Future Meeting)
... Pharmaceutical chemist at Abbott Laboratories (AbbVie) and coinventor of the protease inhibitor
Feb 23, 2021
... Pharmaceutical chemist at Abbott Laboratories (AbbVie) and coinventor of the protease inhibitor
Feb 23, 2021
8.2 David Ho — Unraveling of HIV Dynamics In Vivo
(HIV/AIDS Research: Its History & Future Meeting)
... meeting. We go to the meeting together. That chap was Dale Kempf who is a chemist for Abbott. He had told me that he was working on these small molecules that will intercalate into the protease ...
Apr 27, 2021
... meeting. We go to the meeting together. That chap was Dale Kempf who is a chemist for Abbott. He had told me that he was working on these small molecules that will intercalate into the protease ...
Apr 27, 2021
2.3 Mark Harrington — The Importance of Activism to the US Response
(HIV/AIDS Research: Its History & Future Meeting)
... answers about the protease inhibitors. That led to a flurry of new trial designs, including the Abbott Laboratories trial of ritonavir, RTV, which showed a 50% reduction in deaths in six ...
Apr 27, 2021
... answers about the protease inhibitors. That led to a flurry of new trial designs, including the Abbott Laboratories trial of ritonavir, RTV, which showed a 50% reduction in deaths in six ...
Apr 27, 2021
8.1 John Mellors — MACS and Beyond: Epidemiology, Viremia and Pathogenesis
(HIV/AIDS Research: Its History & Future Meeting)
... assay to ask a variety of clinical questions. The one I was most interested in was the study Abbott 98863 which was a comparison of lopinavir/ritonavir to nelfinavir. (20) There was a marked, highly statistically ...
Apr 27, 2021
... assay to ask a variety of clinical questions. The one I was most interested in was the study Abbott 98863 which was a comparison of lopinavir/ritonavir to nelfinavir. (20) There was a marked, highly statistically ...
Apr 27, 2021